Nov Stock

Nov EBIT

The EBIT of Nov (NOV) as of Jun 21, 2026 is 677 T USD.In the previous year, EBIT was 879 T USD — a change of -22.98% (lower).

EBIT

677 TUSD

YoY

-22.98%

Last updated:

In 2026, Nov's EBIT was 677 T USD, a -22.98% increase from the 879 T USD EBIT recorded in the previous year.

The Nov EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B USD)
Date
EBIT (B USD)
Jan 1, 2006
1.12 base
Jan 1, 2007
2.04 base
Jan 1, 2008
2.92 base
Jan 1, 2009
2.46 base
Jan 1, 2010
2.45 base
Jan 1, 2011
2.94 base
Jan 1, 2012
3.39 base
Jan 1, 2013
3.2 base
Jan 1, 2014
3.72 base
Jan 1, 2015
1.3 base
Jan 1, 2016
-1.44 base
Jan 1, 2017
-0.28 base
Jan 1, 2018
0.21 base
Jan 1, 2019
-0.46 base
Jan 1, 2020
-0.53 base
YEAREBIT (B USD)
2030 est -
2029 est -
2028 est 0.83
2027 est 0.75
2026 est 0.66
2025 0.68
2024 0.88
2023 0.65
2022 0.26
2021 -0.13
2020 -0.53
2019 -0.46
2018 0.21
2017 -0.28
2016 -1.44
2015 1.3
2014 3.72
2013 3.2
2012 3.39
2011 2.94
2010 2.45
2009 2.46
2008 2.92
2007 2.04
2006 1.12
Access this data via the Eulerpool API

Nov Revenue

Nov Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
7.03 B USD
1.12 B USD
684 M USD
Jan 1, 2007
9.79 B USD
2.04 B USD
1.34 B USD
Jan 1, 2008
13.43 B USD
2.92 B USD
1.95 B USD
Jan 1, 2009
12.71 B USD
2.46 B USD
1.47 B USD
Jan 1, 2010
12.16 B USD
2.45 B USD
1.67 B USD
Jan 1, 2011
14.66 B USD
2.94 B USD
1.99 B USD
Jan 1, 2012
17.19 B USD
3.39 B USD
2.49 B USD
Jan 1, 2013
19.22 B USD
3.2 B USD
2.33 B USD
Jan 1, 2014
21.44 B USD
3.72 B USD
2.5 B USD
Jan 1, 2015
14.76 B USD
1.3 B USD
-769 M USD
Jan 1, 2016
7.25 B USD
-1.44 B USD
-2.41 B USD
Jan 1, 2017
7.3 B USD
-277 M USD
-237 M USD
Jan 1, 2018
8.45 B USD
211 M USD
-31 M USD
Jan 1, 2019
8.48 B USD
-458 M USD
-6.1 B USD
Jan 1, 2020
6.09 B USD
-534 M USD
-2.54 B USD

Nov Margins

Nov stock margins

The Nov margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nov. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nov.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
25.06 %
15.93 %
9.74 %
Jan 1, 2007
28.91 %
20.88 %
13.66 %
Jan 1, 2008
30.32 %
21.73 %
14.53 %
Jan 1, 2009
29.77 %
19.37 %
11.56 %
Jan 1, 2010
31.52 %
20.13 %
13.71 %
Jan 1, 2011
30.68 %
20.04 %
13.6 %
Jan 1, 2012
29.33 %
19.71 %
14.49 %
Jan 1, 2013
26.55 %
16.64 %
12.11 %
Jan 1, 2014
27.09 %
17.34 %
11.67 %
Jan 1, 2015
20.76 %
8.8 %
-5.21 %
Jan 1, 2016
-1.39 %
-19.85 %
-33.26 %
Jan 1, 2017
12.21 %
-3.79 %
-3.24 %
Jan 1, 2018
17.08 %
2.5 %
-0.37 %
Jan 1, 2019
9.97 %
-5.4 %
-71.88 %
Jan 1, 2020
7.13 %
-8.77 %
-41.74 %

Nov Stock analysis

What does Nov do? Nov Inc is a globally operating company that was founded in the USA in 1976. The company specializes in the development and manufacture of products in various fields, including pharmaceuticals, biotechnology, agrochemicals, and electronics. Nov Inc's business model is based on the research and development of new technologies and products. The company invests a significant portion of its resources in the research and development of new drugs and technologies. Nov Inc works closely with scientific organizations and universities to achieve this. The goal of Nov Inc is to develop products that have a positive impact on health, science, and the environment. The company aims to improve the quality of life for people worldwide by developing innovative products that meet the needs of its customers. Nov Inc is divided into several divisions. The main divisions are pharmaceuticals, biotechnology, diagnostics, crop protection, and electronics. In each of these divisions, the company produces products tailored to the needs of its customers. In the pharmaceutical field, Nov Inc develops and produces drugs for the treatment of various diseases such as cancer, diabetes, and cardiovascular diseases. Nov Inc's products are well-known worldwide and are taken by millions of patients every day. The company is proud to make a significant contribution to improving the health of people worldwide. In the biotechnology division, Nov Inc develops products for use in agriculture and environmental protection. This includes improved seed varieties that are more resistant to insects and diseases, thus reducing the use of pesticides. Nov Inc also produces biological pesticides that protect plants from pests while being non-toxic and environmentally friendly. In the diagnostics division, Nov Inc develops and produces tests for the diagnosis of infectious diseases and other medical conditions. These tests are important for the timely detection of diseases and enable early treatment. In the electronics division, Nov Inc develops and produces electronic devices and components. This includes semiconductors, sensors, and displays. These components are used in various industries, including telecommunications, automotive, and aerospace. In addition to the above-mentioned divisions, Nov Inc also offers other products, including food additives, colorants, fragrances, and chemicals for industrial use. Overall, Nov Inc has made a significant contribution to improving health, science, and the environment over the past decades. The company is globally recognized for its innovative products and technologies and will remain an important player in research and development in the future. Nov is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Nov's EBIT

Nov's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Nov's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Nov's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Nov’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Nov stock

EBIT of Nov amounted to 879 T USD 677 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Nov

All Key Metrics — Nov